Ligand validation:2GSK

LDA: LAURYL DIMETHYLAMINE-N-OXIDE

LDA is a Ligand Of Interest in 2GSK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GSK_LDA_A_802	20%	70%	0.185	0.811	0.54	0.63	-	-	0	0	88%	0.875
2GSK_LDA_A_801	16%	31%	0.237	0.807	1.71	1.04	1	1	0	0	100%	1
2GSK_LDA_A_800	16%	9%	0.235	0.813	3.84	0.78	2	-	2	0	94%	0.9375
2GSK_LDA_A_803	5%	56%	0.273	0.715	1.05	0.66	1	-	3	0	88%	0.875
1UJW_LDA_A_603	33%	36%	0.272	0.951	1.79	0.75	1	-	0	0	100%	1
2VQI_LDA_B_1639	100%	35%	0.04	0.995	2.08	0.52	1	-	3	0	100%	1
6PRC_LDA_H_701	97%	23%	0.047	0.959	2.52	0.69	2	-	0	0	100%	1
3PRC_LDA_H_701	95%	24%	0.049	0.954	2.42	0.76	2	-	0	0	100%	1
2PRC_LDA_M_701	95%	25%	0.048	0.95	2.43	0.69	2	-	0	0	100%	1
5PRC_LDA_H_701	95%	20%	0.052	0.954	2.65	0.78	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.